Arbital Health, an AI platform to help manage value-based care contracts, announced it secured $31 million in Series B funding.
Valtruis led the round, with participation from existing investors Shaper Capital, Transformation Capital and Healthy Ventures.
WHAT IT DOES
The San Francisco-based company, founded in 2024, offers an AI-enabled platform that centralizes value-based care contracts, predicts financial outcomes and measures performance across contracts.
Arbital also offers actuarial and healthcare guidance to sales teams to quantify risks associated with value-based care contracts.
The company will use the funds to expand its payer- and provider-facing capabilities, scale and enhance its platform, and expand its actuarial workforce.
"With healthcare's top actuaries and an advanced AI-powered platform, Arbital Health is addressing the financial and performance issues that have long held back value-based care's success. We're proud to support their team as they continue to drive growth, value, and better outcomes in healthcare," Mike Spadafore, managing director at Valtruis, said in a statement.
MARKET SNAPSHOT
Earlier this year, Arbital Health announced a partnership with HarmonyCares, an in-home primary care services provider for people with complex care needs. HarmonyCares was to use Arbital's services for its value-based care arrangements.
Arbital also partnered with primary care-focused Aligned Marketplace, which works with self-insured employers, to support its primary care model through value-based contracting.
Last year, Arbital Health announced a long-term collaboration with Quartet Health, a virtual mental and behavioral health platform, to support Quartet's Whole Health program that aims to lower costs and improve patient outcomes for individuals diagnosed with serious mental illness.
The company also partnered with Podimetrics, which helps patients with diabetes prevent serious complications.
Through the collaboration, Arbital will work to quantify risk and improve value-based care by helping Podimetrics understand the size and severity of specific diabetic foot ulcer (DFU) issues, deploy machine learning technology to identify patients most likely to experience a DFU and create contracting approaches for Podimetric's health plan and provider partners.
